Seeing Is Believing
Currently out of the existing stock ratings of Akash Tewari, 98 are a BUY (77.17%), 25 are a HOLD (19.69%), 4 are a SELL (3.15%).
Analyst Akash Tewari, currently employed at JEFFERIES, carries an average stock price target met ratio of 46.92% that have a potential upside of 26.55% achieved within 202 days.
Akash Tewari’s has documented 242 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 01-Sep-2025.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 6/21/2022. The price target of $42 was fulfilled within 2 days with a profit of $3.11 (8%) receiving and performance score of 39.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$35
$3.79 (12.14%)
$34
1 months 6 days ago
(09-Sep-2025)
8/9 (88.89%)
$7.15 (25.67%)
112
Hold
$46
$14.79 (47.39%)
$46
1 months 6 days ago
(09-Sep-2025)
19/25 (76%)
$18.15 (65.17%)
295
Buy
$45
$13.79 (44.18%)
$45
2 months 16 days ago
(29-Jul-2025)
0/3 (0%)
$18 (66.67%)
Buy
$42
$10.79 (34.57%)
$38
3 months 28 days ago
(17-Jun-2025)
2/4 (50%)
$12.23 (41.08%)
86
Buy
$41
$9.79 (31.37%)
$38
5 months 13 days ago
(02-May-2025)
0/2 (0%)
$9.22 (29.01%)
Which stock is Akash Tewari is most bullish on?
Which stock is Akash Tewari is most reserved on?
What Year was the first public recommendation made by Akash Tewari?